Regulation of Neurotropic Signaling by the Inducible, NF-kB-Sensitive miRNA-125b in Alzheimer's Disease (AD) and in Primary Human Neuronal-Glial (HNG) Cells

Molecular Neurobiology

Volumn 50, Issue 1, 2014, Pages 97-106

  Zhao, Yuhai ^a   Bhattacharjee, Surjyadipta ^a   Jones, Brandon M ^a   Hill, Jim ^b   Dua, Prerna ^c   Lukiw, Walter J ^a,b,d  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d LSU Neuroscience Center   (United States)

Author keywords

15 lipoxygenase (15 LOX); Alzheimer's disease (AD); Innate immune response; MicroRNA (miRNA); miRNA 125b; ncRNA; Neuro inflammation; Neuroprotectin D1 (NPD1); Vitamin D receptor (VDR)

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; COLECALCIFEROL RECEPTOR; DOCOSAHEXAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICRORNA 125B; MICRORNA 146A; MICRORNA 155; MICRORNA 34A; MICRORNA 9; NEUROPROTECTIN D1; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; MICRORNA; MIRN125 MICRORNA, HUMAN; NERVE GROWTH FACTOR;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; BIOINFORMATICS; BRAIN TISSUE; CEREBROSPINAL FLUID; DOT HYBRIDIZATION; DOWN REGULATION; EXTRACELLULAR FLUID; GENE EXPRESSION; GLIA CELL; HUMAN; IMMUNOBLOTTING; NEUROTROPISM; PATHOGENESIS; REVIEW; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; GENETICS; GLIA; METABOLISM; NERVE CELL;

ALZHEIMER DISEASE; HUMANS; MICRORNAS; NERVE GROWTH FACTORS; NEUROGLIA; NEURONS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84911008143     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8595-3     Document Type: Review

References (80)

1. Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355
2. Perron MP, Provost P (2009) Protein components of the microRNA pathway and human diseases. Methods Mol Biol 487:369–385
3. Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18:297–300
4. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS (2010) Non-coding RNAs: regulators of disease. J Pathol 220:126–139
5. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835–840
6. Lukiw WJ, Pogue AI (2007) Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J Inorg Biochem 101:1265–1269
7. Sethi P, Lukiw WJ (2009) Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 459:100–104
8. Mehler MF, Mattick JS (2007) Noncoding RNAs and RNA editing in brain development, functional diversification and neurological disease. Physiol Rev 87:799–823
9. Rüegger S, Großhans H (2012) MicroRNA turnover: when, how, and why. Trends Biochem Sci 37:436–446
10. Cui JG, Li YY, Zhao Y, Bhattacharjee S, Lukiw WJ (2010) Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by miRNA-146a and NF-kB in stressed human astroglial cells and in Alzheimer's disease. J Biol Chem 285:38951–38960
11. Lukiw WJ, Handley P, Wong L, McLachlan DRC (1992) BC200 and other small RNAs RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). Neurochem Res 17:591–597
12. Tsitsiou E, Lindsay MA (2009) microRNAs and the immune response. Curr Opin Pharmacol 9:514–520
13. Lukiw WJ, Cui JG, Yuan LY, Bhattacharjee PS, Corkern M, Clement C et al (2010) Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. Neuroreport 21:922–927
14. Madathil SK, Nelson PT, Saatman KE, Wilfred BR (2011) MicroRNAs in CNS injury: potential roles and therapeutic implications. Bioessays 33:21–26
15. Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ (2012) microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 3:365–373
16. Hulse AM, Cai JJ (2013) Genetic variants contribute to gene expression variability. Genetics 193:95–108
17. Cowley MJ, Cotsapas CJ, Williams RB, Chan EK, Pulvers JN, Liu MY, Luo OJ, Nott DJ, Little PF (2009) Intra- and inter-individual genetic differences in gene expression. Mamm Genome 20:281–295
18. Olson MV (2012) Human genetic individuality. Annu Rev Genomics Hum Genet 13:1–27
19. Hébert SS, Nelson PT (2012) Studying microRNAs in the brain: technical lessons learned from the first ten years. Exp Neurol 235:397–401
20. Lukiw WJ (2013) Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD). Front Cell Neurosci 7:133–136
21. Chen X, Liang H, Zhang J, Zen K, Zhang CY (2012) Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22:125–132
22. Raj A, Rifkin SA, Andersen E, van Oudenaarden A (2010) Variability in gene expression underlies incomplete penetrance. Nature 463:913–918
23. Zheng W, Gianoulis TA, Karczewski KJ, Zhao H, Snyder M (2011) Regulatory variation within and between species. Annu Rev Genomics Hum Genet 12:327–346
24. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R (2001) A gene expression profile of Alzheimer's disease. DNA Cell Biol 20:683–695
25. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Lukiw WJ (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70:462–473
26. Lukiw WJ (2004) Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem Res 29:1287–1297
27. Ginsberg SD, Alldred MJ, Che S (2012) Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer’s disease. Neurobiol Dis 45:99–107. doi:10.1016/j.nbd.2011.07.013
28. Kaltschmidt B, Kaltschmidt C (2009) NF-kappaB in the nervous system. Cold Spring Harb Perspect Biol 1:a001271
29. Lukiw WJ, Bazan NG (1998) Strong NF-kB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J Neurosci Res 53:583–592
30. Lukiw WJ (2012) NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease. Alzheimers Res Ther 4:47–52
31. Lukiw WJ (2013) Antagonism of NF-kB-up-regulated micro RNAs (miRNAs) in sporadic Alzheimer's disease (AD)-anti-NF-κB vs. anti-miRNA strategies. Front Genet 4:77
32. Lukiw WJ, Andreeva TV, Grigorenko AP, Rogaev EI (2012) Studying micro RNA function and dysfunction in Alzheimer's disease. Front Genet 3:327–340
33. Peng T, Jia YJ, Wen QQ, Guan WJ, Zhao EY, Zhang BA (2010) Expression of microRNA in neonatal rats with hypoxic-ischemic brain damage. Zhongguo Dang Dai Er Ke Za Zhi 12:373–376
34. Pogue AI, Cui JG, Li YY, Zhao Y, Culicchia F, Lukiw WJ (2010) Micro RNA-125b (miRNA-125b) function in astrogliosis and glial cell proliferation. Neurosci Lett 476:18–22
35. Wan Y, Fei XF, Wang ZM, Jiang DY, Chen HC, Yang J, Shi L, Huang Q (2012) Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chin J Cancer 31:207–214
36. Lukiw WJ, Alexandrov PN (2012) Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain. Mol Neurobiol 46:11–19
37. Lukiw WJ, Surjyadipta B, Dua P, Alexandrov PN (2012) Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer's disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol 3:105–116
38. Lukiw WJ (2012) NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp Neurol 235:484–490
39. Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human neural cells. J Biol Chem 283:31315–31322
40. Nelson PT, Dimayuga J, Wilfred BR (2010) microRNA in situ hybridization in the human entorhinal and transentorhinal cortex. Front Hum Neurosci 4:7–11
41. Le MT, Xie H, Zhou B, Chia PH, Rizk P, Um M, Udolph G, Yang H, Lim B, Lodish HF (2009) MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol Cell Biol 29:5290–5305
42. Shi Y, Huang F, Tang B, Li J, Wang J, Shen L, Xia K, Jiang H (2013) MicroRNA profiling in the serums of SCA3/MJD patients. Int J Neurosci. 2013 in press
43. Bazan NG, Calandria JM, Gordon WC (2013) Docosahexaenoic acid and its derivative neuroprotectin D1 display neuroprotective properties in the retina, brain and central nervous system. Nestle Nutr Inst Workshop Ser 77:121–131
44. Orr SK, Palumbo S, Bosetti F, Mount HT, Kang JX, Greenwood CE, Ma DW, Serhan CN, Bazinet RP (2013) Unesterified docosahexaenoic acid is protective in neuroinflammation. J Neurochem 127:378–393
45. Hennig R, Kehl T, Noor S, Ding XZ, Rao SM, Bergmann F, Fürstenberger G, Büchler MW, Friess H, Krieg P, Adrian TE (2007) 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. Neoplasia 9:917–926
46. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic cid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115:2774–2783
47. Palacios-Pelaez R, Lukiw WJ, Bazan NG (2010) Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol 41:367–374
48. Uderhardt S, Krönke G (2012) 12/15-lipoxygenase during the regulation of inflammation, immunity, and self-tolerance. J Mol Med (Berl) 90:1247–1256
49. Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T (2009) MicroRNA regulates human vitamin D receptor. Int J Cancer 125:1328–1333
50. Lehmann DJ, Refsum H, Warden DR, Medway C, Wilcock GK, Smith AD (2011) The vitamin D receptor gene is associated with Alzheimer's disease. Neurosci Lett 504:79–82
51. Wang L, Hara K, Van Baaren JM, Price JC, Beecham GW, Gallins PJ, Whitehead PL, Wang G, Lu C, Slifer MA, Züchner S, Martin ER, Mash D, Haines JL, Pericak-Vance MA, Gilbert JR (2012) Vitamin D receptor and Alzheimer's disease: a genetic and functional study. Neurobiol Aging 33:1844
52. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13:100–105
53. Lu'o'ng KV, Nguyen LT (2013) The role of vitamin D in Alzheimer's disease: possible genetic and cell signaling mechanisms. Am J Alzheimers Dis Other Demen 28:126–136
54. DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC (2013) Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol 39:458–484
55. Nissou MF, Brocard J, El Atifi M, Guttin A, Andrieux A, Berger F, Issartel JP, Wion D (2013) The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases. J Alzheimers Dis 35:553–564
56. Dursun E, Gezen-Ak D, Yilmazer S (2013) Beta amyloid suppresses the expression of the vitamin D receptor gene and induces the expression of the vitamin d catabolic enzyme gene in hippocampal neurons. Dement Geriatr Cogn Disord 36:76–86
57. Pahl L, Schubert S, Skawran B, Sandbothe M, Schmidtke J, Stuhrmann M (2013) 1,25-Dihydroxyvitamin D decreases HTRA1 promoter activity in the rhesus monkey—a plausible explanation for the influence of vitamin D on age-related macular degeneration? Exp Eye Res 116C:234–239
58. Annweiler C, Brugg B, Peyrin JM, Bartha R, Beauchet O (2013) Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol Aging 35:331–335
59. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, Zhang SM, Buring JE (2012) The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 33:159–171
60. Holló A, Clemens Z, Lakatos P (2013) Epilepsy and Vitamin D. Int J Neurosci. in press
61. Taghizadeh M, Talaei SA, Djazayeri A, Salami M (2013) Vitamin D supplementation restores suppressed synaptic plasticity in Alzheimer's disease. Nutr Neurosci. in press
62. Boldin MP, Baltimore D (2012) MicroRNAs, new effectors and regulators of NF-κB. Immunol Rev 246:205–220
63. Pogue AI, Li YY, Cui JG, Zhao Y, Kruck TP, Percy ME, Tarr MA, Lukiw WJ (2009) Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. J Inorg Biochem 103:1591–1595
64. Riazanskaia N, Lukiw WJ, Grigorenko A, Korovaitseva G, Dvoryanchikov G, Moliaka Y, Nicolaou M, Farrer L, Bazan NG, Rogaev E (2002) Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD. Mol Psychiatry 7:891–898
65. McLachlan DR, Lukiw WJ, Kruck TP (1989) New evidence for an active role of aluminum in Alzheimer's disease. Can J Neurol Sci 16:490–497
66. Hill JM, Zhao Y, Clement C, Neumann DM, Lukiw WJ (2009) HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling. Neuroreport 20:1500–1505
67. Bredy TW, Lin Q, Wei W, Baker-Andresen D, Mattick JS (2011) MicroRNA regulation of neural plasticity and memory. Neurobiol Learn Mem 96:89–94
68. Niemitz E (2012) TREM2 and Alzheimer's disease. Nat Genet 45:11–12
69. Heneka MT, O'Banion MK, Terwel D, Kummer MP (2010) Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 117:919–947
70. Xu D, Sharma C, Hemler ME (2009) Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J 23:3674–3681
71. Zhao Y, Bhattacharjee S, Jones BM, Dua P, Alexandrov PN, Hill JM, Lukiw WJ (2013) Regulation of TREM2 expression by an NF-кB-sensitive miRNA-34a. Neuroreport 24:318–323
72. Sen R, Baltimore D (1986) Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47:921–928
73. Gilmore TD, Herscovitch M (2006) Inhibitors of NF-kB signaling: 785 and counting. Oncogene 25:6887–6899
74. Gilmore TD, Garbati MR (2011) Inhibition of NF-κB signaling as a strategy in disease therapy. Curr Top Microbiol Immunol 349:245–263
75. Nam NH (2006) Naturally occurring NF-kB inhibitors. Mini Rev Med Chem 6:945–951
76. Chen X, Liang H, Zhang CY, Zen K (2012) miRNA regulates noncoding RNA: a noncanonical function model. Trends Biochem Sci 37:457–459
77. Lukiw WJ, Alexandrov PN, Zhao Y, Hill JM, Bhattacharjee S (2012) Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA. Neuroreport 23:621–626
78. Pogue AI, Percy ME, Cui JG, Li YY, Bhattacharjee S, Hill JM, Kruck TP, Zhao Y, Lukiw WJ (2011) Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures. J Inorg Biochem 105:1434–1437
79. Lecrux C, Hamel E (2011) The neurovascular unit in brain function and disease. Acta Physiol (Oxf) 203:47–59
80. Erickson MA, Banks WA (2013) Blood–brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab 33:1500–1513